Event Type: Q4 and FY26 Earnings Conference Call hosted by Confideleap Partners to discuss financial results.
Event Date & Time: Thursday, June 18, 2026 at 04:00 PM IST. Event duration was 39 minutes and 30 seconds.
Purpose: Discussion of the company's financial results for the Quarter and Year Ended March 31, 2026 and strategic business updates.
Management Participants: Mr. Gaurang Shah (Chairman & Managing Director) represented the company. Ms. Vijeeta Dave from Confideleap Partners was also present as the host.
Availability of Materials: The transcript of the earnings call was made available on the company's website at https://www.kotyark.com/schedule-of-analysts. The company indicated that certain forward-looking statements were made during the call subject to risks and uncertainties.
Financial Period Discussed: Q4 and FY26 (Year Ended March 31, 2026).
Forward-Looking Statements: Management expressed confidence in gradually improving utilization levels to 60-70% over the next few years. Growth expectation of 15-20% in revenue and capacity utilization for the upcoming period. Margins are expected to be 8-10%, with potential improvement as utilization increases.
Strategic Themes: Expansion of biodiesel production capacity at Rajasthan facility from 500 KLPD to 1500 KLPD (cumulative annual capacity ~480,000 KL). Plans to set up two new manufacturing facilities at Jhajjar (Haryana) and Kanpur (Uttar Pradesh), each with 200 KLPD capacity, expected commissioning by December 2026. Funding through internal accruals. Focus on multi-feedstock processing (10-15 feedstocks), value extraction through byproducts (glycerin business), and sustainability initiatives (Vera carbon certification, 57,000+ carbon credits generated).
Order Book & Pipeline: Executable order book of ~₹80 crore (OMCs and other customers, expected execution over next 3 months). Pipeline of ~₹215 crore being pursued.
Compliance Language: The company included standard forward-looking statement disclaimer noting that actual results may differ materially due to various risks and uncertainties. The company undertook no obligation to publicly update or revise any forward-looking statements.
Additional Notes Section
Attachments: The regulatory filing intimates that the transcript of the earnings call was enclosed and made available on the website.
Financial Data: Financial figures for FY26 (Revenue, EBITDA, PAT) were disclosed in the transcript. No other unpublished price sensitive information (UPSI) was indicated to be shared.
Logistical Details: Dial-in numbers or access codes were not included in the provided transcript excerpt.
